Mesa Laboratories MLAB Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×— | 0.6×— | 0.6×— | 0.5×— | |
| Liquidity | ||||||
| Current ratio | 1.7×+1.1× | 1.9×+1.3× | 2×+1.3× | 0.7×-1.3× | 0.6×-1.8× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×-0.6× | 0.4×-0.7× | 0.4×-0.7× | 1×+0.5× | 1×+1.0× | |
| Valuation | ||||||
| Market capitalization | $542.27M+3.7% | $433.5M-39.5% | $368.65M-47.4% | $537.85M+14.9% | $644.75M+9.0% | |
| Price / sales | 2.2×0.0× | 1.8×-1.3× | 1.5×-1.6× | 2.2×+0.1× | 2.7×-0.1× | |
| Price / book | 2.9×-0.4× | 2.3×-2.3× | 2.1×-2.3× | 3.1×0.0× | 4×0.0× | |
| Dividend yield | 0.6%0.0pp | 0.8%+0.3pp | 0.9%+0.5pp | 0.6%-0.1pp | 0.5%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Mesa Laboratories's profit margins?
- Mesa Laboratories (MLAB) runs a 56.8% gross margin and a 2.3% operating margin, with a 1.5% net margin.
- Where do Mesa Laboratories's ratios come from?
- Every ratio is computed from Mesa Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
